A glance at G-protein-coupled receptors for lipid mediators: a growing receptor family with remarkably diverse ligands.
暂无分享,去创建一个
[1] M. Parmentier,et al. Functional Characterization of Human Receptors for Short Chain Fatty Acids and Their Role in Polymorphonuclear Cell Activation* , 2003, Journal of Biological Chemistry.
[2] S. Pyne,et al. Sphingosine 1-phosphate signalling via the endothelial differentiation gene family of G-protein-coupled receptors. , 2000, Pharmacology & therapeutics.
[3] Y. Igarashi,et al. Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum. , 1997, Journal of biochemistry.
[4] R. Getzenberg,et al. Increased expression of CYR61, an extracellular matrix signaling protein, in human benign prostatic hyperplasia and its regulation by lysophosphatidic acid. , 2004, Endocrinology.
[5] G. Mills,et al. The emerging role of lysophosphatidic acid in cancer , 2003, Nature Reviews Cancer.
[6] J. McGarry,et al. A fatty acid- dependent step is critically important for both glucose- and non-glucose-stimulated insulin secretion. , 1998, The Journal of clinical investigation.
[7] G Vassart,et al. Molecular cloning of an orphan G-protein-coupled receptor that constitutively activates adenylate cyclase. , 1995, The Biochemical journal.
[8] C. Chang,et al. Pituitary adenylate cyclase-activating polypeptide stimulates cholecystokinin secretion in STC-1 cells. , 1996, The American journal of physiology.
[9] T. Yokota,et al. LSSIG is a novel murine leukocyte-specific GPCR that is induced by the activation of STAT3. , 2003, Blood.
[10] J. Weiner,et al. Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[11] J. Chun,et al. Characterization of lpa2 (Edg4) and lpa1/lpa2 (Edg2/Edg4) Lysophosphatidic Acid Receptor Knockout Mice: Signaling Deficits without Obvious Phenotypic Abnormality Attributable to lpa2 , 2002, Molecular and Cellular Biology.
[12] A. Morris,et al. Lysophosphatidic acid signaling: how a small lipid does big things. , 2003, Trends in biochemical sciences.
[13] R. Kedzierski,et al. Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[14] O. Witte,et al. Lysophosphatidylcholine as a Ligand for the Immunoregulatory Receptor G2A , 2001, Science.
[15] L. F. Kolakowski,et al. A cluster of four novel human G protein-coupled receptor genes occurring in close proximity to CD22 gene on chromosome 19q13.1. , 1997, Biochemical and biophysical research communications.
[16] S. Watanabe,et al. Inhibition of tumor necrosis factor-alpha and interleukin-1-beta production by beta-adrenoceptor agonists from lipopolysaccharide-stimulated human peripheral blood mononuclear cells. , 1997, Pharmacology.
[17] H. Suh,et al. Therapeutic effects of lysophosphatidylcholine in experimental sepsis , 2004, Nature Medicine.
[18] K. Jalink,et al. Sphingosine‐1‐phosphate rapidly induces Rho‐dependent neurite retraction: action through a specific cell surface receptor. , 1996, The EMBO journal.
[19] K. Jakobs,et al. Guanine nucleotide-sensitive inhibition of L-type Ca2+ current by lysosphingolipids in RINm5F insulinoma cells. , 1998, Molecular pharmacology.
[20] S. Pyne,et al. Sphingosine 1-phosphate signalling in mammalian cells , 2000 .
[21] T. Hla,et al. An abundant transcript induced in differentiating human endothelial cells encodes a polypeptide with structural similarities to G-protein-coupled receptors. , 1990, The Journal of biological chemistry.
[22] Masataka Harada,et al. A G Protein-coupled Receptor Responsive to Bile Acids* , 2003, The Journal of Biological Chemistry.
[23] K. Jakobs,et al. Evidence for Edg-3 receptor-mediated activation of I(K.ACh) by sphingosine-1-phosphate in human atrial cardiomyocytes. , 2000, Molecular pharmacology.
[24] K. Jakobs,et al. A distinct G(i) protein-coupled receptor for sphingosylphosphorylcholine in human leukemia HL-60 cells and human neutrophils. , 1996, Molecular pharmacology.
[25] G. FitzGerald,et al. Genetic and pharmacological analysis of prostanoid receptor function. , 2001, The Journal of clinical investigation.
[26] S. Ashcroft,et al. Acute effects of fatty acids on insulin secretion from rat and human islets of Langerhans. , 2002, The Journal of endocrinology.
[27] Peter J. Brown,et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ , 1997 .
[28] B. Olde,et al. Identification of a free fatty acid receptor, FFA2R, expressed on leukocytes and activated by short-chain fatty acids. , 2003, Biochemical and biophysical research communications.
[29] J. Weiner,et al. Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex , 1996, The Journal of cell biology.
[30] J. Rokach,et al. Eotaxin and RANTES enhance 5-oxo-6,8,11,14-eicosatetraenoic acid-induced eosinophil chemotaxis. , 2001, The Journal of allergy and clinical immunology.
[31] T. Rabelink,et al. Albumin restores lysophosphatidylcholine-induced inhibition of vasodilation in rat aorta. , 2001, Kidney international.
[32] J. Chambers,et al. The Orphan G Protein-coupled Receptor GPR40 Is Activated by Medium and Long Chain Fatty Acids* , 2003, The Journal of Biological Chemistry.
[33] R. Breyer,et al. Prostanoid receptors: subtypes and signaling. , 2001, Annual review of pharmacology and toxicology.
[34] D. Stainier,et al. A sphingosine-1-phosphate receptor regulates cell migration during vertebrate heart development , 2000, Nature.
[35] S. Pyne,et al. Assessment of agonism at G‐protein coupled receptors by phosphatidic acid and lysophosphatidic acid in human embryonic kidney 293 cells , 2001, British journal of pharmacology.
[36] J. Lecerf,et al. Human plasma albumin transports [13C]docosahexaenoic acid in two lipid forms to blood cells. , 1997, Journal of lipid research.
[37] J. Friedman,et al. Selective deletion of leptin receptor in neurons leads to obesity. , 2001, The Journal of clinical investigation.
[38] A. Mantovani,et al. Stimulating properties of 5-oxo-eicosanoids for human monocytes: synergism with monocyte chemotactic protein-1 and -3. , 1996, Journal of immunology.
[39] Y. Pinchasov,et al. Broiler chick responses to anorectic agents: dietary acetic and propionic acids and the blood metabolites. , 1995, Annals of nutrition & metabolism.
[40] J. McGarry,et al. Essentiality of circulating fatty acids for glucose-stimulated insulin secretion in the fasted rat. , 1996, The Journal of clinical investigation.
[41] S. Muro,et al. 5-oxo-6,8,11,14-eicosatetraenoic acid induces the infiltration of granulocytes into human skin. , 2003, The Journal of allergy and clinical immunology.
[42] Y. Sugimoto,et al. Prostanoid receptor subtypes. , 2002, Prostaglandins & other lipid mediators.
[43] M. Moskowitz,et al. Sphingosine‐1‐phosphate induces proliferation and morphological changes of neural progenitor cells , 2004, Journal of neurochemistry.
[44] Li V. Yang,et al. T cell chemotaxis to lysophosphatidylcholine through the G2A receptor , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[45] Takao Shimizu,et al. Identification of p2y9/GPR23 as a Novel G Protein-coupled Receptor for Lysophosphatidic Acid, Structurally Distant from the Edg Family* , 2003, Journal of Biological Chemistry.
[46] H. Webster. Effects of Psychosine (Galactosylsphingosine) on the Survival and the Fine Structure of Cultured Schwann Cells , 1993, Journal of neuropathology and experimental neurology.
[47] T. Hla,et al. Differential Pharmacological Properties and Signal Transduction of the Sphingosine 1-Phosphate Receptors EDG-1, EDG-3, and EDG-5* , 1999, The Journal of Biological Chemistry.
[48] J. P. Hobson,et al. Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. , 2000, The Journal of clinical investigation.
[49] N. Yamamoto,et al. Effects of inflammation products on immune systems , 1986, Cancer Immunology, Immunotherapy.
[50] Valéria Szukacsov,et al. Lysophosphatidylcholine is a regulator of tyrosine kinase activity and intracellular Ca(2+) level in Jurkat T cell line. , 2004, Immunology letters.
[51] G. Mills,et al. Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.
[52] H. Rosen,et al. Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists , 2002, Science.
[53] Sarah Spiegel,et al. Sphingosine-1-phosphate: an enigmatic signalling lipid , 2003, Nature Reviews Molecular Cell Biology.
[54] K. Fukuzawa,et al. Human platelets respond differentially to lysophosphatidic acids having a highly unsaturated fatty acyl group and alkyl ether-linked lysophosphatidic acids. , 2002, The Biochemical journal.
[55] J. McGarry,et al. The insulinotropic potency of fatty acids is influenced profoundly by their chain length and degree of saturation. , 1997, The Journal of clinical investigation.
[56] S. Dowell,et al. The Orphan G Protein-coupled Receptors GPR41 and GPR43 Are Activated by Propionate and Other Short Chain Carboxylic Acids* , 2003, The Journal of Biological Chemistry.
[57] Simon C Watkins,et al. The Recruitment of Raf-1 to Membranes Is Mediated by Direct Interaction with Phosphatidic Acid and Is Independent of Association with Ras* , 2000, The Journal of Biological Chemistry.
[58] S. Kimura,et al. The novel sphingosine 1-phosphate receptor AGR16 is coupled via pertussis toxin-sensitive and -insensitive G-proteins to multiple signalling pathways. , 1999, The Biochemical journal.
[59] M. Guilbert,et al. 5-Oxo-6,8,11,14-eicosatetraenoic acid induces important eosinophil transmigration through basement membrane components: comparison of normal and asthmatic eosinophils. , 1999, American journal of respiratory cell and molecular biology.
[60] R. Pietras,et al. Endometrial cell calcium and oestrogen action , 1975, Nature.
[61] Masataka Harada,et al. Free fatty acids regulate insulin secretion from pancreatic β cells through GPR40 , 2003, Nature.
[62] R. Lefkowitz,et al. Multifaceted roles of β-arrestins in the regulation of seven-membrane-spanning receptor trafficking and signalling , 2003 .
[63] A. Verin,et al. Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement. , 2001, The Journal of clinical investigation.
[64] T. Willson,et al. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[65] E. Sugikawa,et al. Identification of a Novel Human Eicosanoid Receptor Coupled to Gi/o * , 2002, The Journal of Biological Chemistry.
[66] C. Der,et al. G2A is an oncogenic G protein-coupled receptor , 2000, Oncogene.
[67] I. Gunnarsson,et al. Antibodies against lysophosphatidylcholine and oxidized LDL in patients with SLE , 1999, Lupus.
[68] Timothy B. Stockwell,et al. The Sequence of the Human Genome , 2001, Science.
[69] S. Milstien,et al. The G protein-coupled receptor GPR4 suppresses ERK activation in a ligand-independent manner. , 2003, Biochemistry.
[70] H. Ochi,et al. Lysophosphatidylcholine enhances cytokine-induced interferon gamma expression in human T lymphocytes. , 1998, Circulation research.
[71] F. Okajima,et al. Pertussis Toxin Inhibits Phospholipase C Activation and Ca2+ Mobilization by Sphingosylphosphorylcholine and Galactosylsphingosine in HL60 Leukemia Cells , 1995, The Journal of Biological Chemistry.
[72] Takao Nakamura,et al. Identification of membrane-type receptor for bile acids (M-BAR). , 2002, Biochemical and biophysical research communications.
[73] D. Steinberg,et al. Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes. , 1993, The Journal of clinical investigation.
[74] J. P. Hobson,et al. Sphingosine 1-Phosphate Stimulates Cell Migration through a Gi-coupled Cell Surface Receptor , 1999, The Journal of Biological Chemistry.
[75] S. Tunaru,et al. Sphingosine 1-phosphate and dioleoylphosphatidic acid are low affinity agonists for the orphan receptor GPR63. , 2003, Cellular signalling.
[76] W. Powell,et al. 5-oxo-6,8,11,14-eicosatetraenoic acid is a potent stimulator of L-selectin shedding, surface expression of CD11b, actin polymerization, and calcium mobilization in human eosinophils. , 1999, American journal of respiratory cell and molecular biology.
[77] J. Zabavnik,et al. Cloning, sequencing and tissue distribution of a candidate G protein‐coupled receptor from rat pituitary gland , 1991, FEBS letters.
[78] Schopf,et al. Synthesis, biological effects and pathophysiological implications of the novel arachidonic acid metabolite 5-oxo-eicosatetraenoic acid (Review). , 1998, International journal of molecular medicine.
[79] Y. Fujiwara,et al. Cyclic phosphatidic acid elicits neurotrophin‐like actions in embryonic hippocampal neurons , 2003, Journal of neurochemistry.
[80] M. Makishima,et al. Identification of a nuclear receptor for bile acids. , 1999, Science.
[81] P. Thomas,et al. Identification, classification, and partial characterization of genes in humans and other vertebrates homologous to a fish membrane progestin receptor , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[82] J. Bockaert,et al. Molecular tinkering of G protein‐coupled receptors: an evolutionary success , 1999, The EMBO journal.
[83] T. Bonner,et al. Molecular cloning and chromosomal localization of human genes encoding three closely related G protein-coupled receptors. , 1995, Genomics.
[84] J. Parinaud,et al. Biochemical characterization of pre-beta 1 high-density lipoprotein from human ovarian follicular fluid: evidence for the presence of a lipid core. , 1996 .
[85] D. Im,et al. The action mode of lysophosphatidylcholine in human monocytes. , 2004, Journal of pharmacological sciences.
[86] J. McGarry,et al. Circulating fatty acids are essential for efficient glucose-stimulated insulin secretion after prolonged fasting in humans. , 1998, Diabetes.
[87] H. Arai,et al. Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species , 2000, FEBS letters.
[88] K. Liliom,et al. Molecular cloning of a high-affinity receptor for the growth factor-like lipid mediator lysophosphatidic acid from Xenopus oocytes. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[89] M. Coppi,et al. Propionate induces polymorphonuclear leukocyte activation and inhibits formylmethionyl-leucyl-phenylalanine-stimulated activation , 1992, Infection and immunity.
[90] H. Selye. CORRELATIONS BETWEEN THE CHEMICAL STRUCTURE AND THE PHARMACOLOGICAL ACTIONS OF THE STEROIDS1 , 1942 .
[91] D J Drucker,et al. Printed in U.S.A. Copyright © 1998 by The Endocrine Society Regulation of Glucagon-Like Peptide-1 Synthesis and , 2022 .
[92] W. Powell,et al. Stimulation of human neutrophils by 5-oxo-6,8,11,14-eicosatetraenoic acid by a mechanism independent of the leukotriene B4 receptor. , 1993, The Journal of biological chemistry.
[93] E. Goetzl,et al. Sphingosine 1‐phosphate and its type 1 G protein‐coupled receptor: trophic support and functional regulation of T Lymphocytes , 2004, Journal of leukocyte biology.
[94] A. Barr,et al. Differential Coupling of the Sphingosine 1-Phosphate Receptors Edg-1, Edg-3, and H218/Edg-5 to the Gi, Gq, and G12 Families of Heterotrimeric G Proteins* , 1999, The Journal of Biological Chemistry.
[95] H. Heng,et al. Cloning of human genes encoding novel G protein-coupled receptors. , 1994, Genomics.
[96] M. Nielen,et al. Beta-hydroxybutyrate levels in peripheral blood and ketone bodies supplemented in culture media affect the in vitro chemotaxis of bovine leukocytes. , 1999, Veterinary immunology and immunopathology.
[97] S. Milstien,et al. Sphingosine 1-Phosphate, a Key Cell Signaling Molecule* , 2002, The Journal of Biological Chemistry.
[98] Kevin R. Lynch,et al. International Union of Pharmacology. XXXIV. Lysophospholipid Receptor Nomenclature , 2002, Pharmacological Reviews.
[99] Y. Kawasawa,et al. Mammalian PSP24s (α and β Isoforms) Are Not Responsive to Lysophosphatidic Acid in Mammalian Expression Systems , 2000 .
[100] H. Heng,et al. Isolation of three novel human genes encoding G protein-coupled receptors. , 1995, DNA and cell biology.
[101] O. Witte,et al. Sphingosylphosphorylcholine and Lysophosphatidylcholine Are Ligands for the G Protein-coupled Receptor GPR4* , 2001, The Journal of Biological Chemistry.
[102] W. Powell,et al. 5-Oxo-6,8,11,14-eicosatetraenoic acid is a potent stimulator of human eosinophil migration. , 1995, Journal of immunology.
[103] J. Lehmann,et al. An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ) (*) , 1995, The Journal of Biological Chemistry.
[104] S. Narumiya,et al. Prostanoid receptors: structures, properties, and functions. , 1999, Physiological reviews.
[105] D. English,et al. Enhancement of the migration of metastatic human breast cancer cells by phosphatidic acid. , 2000, Biochemical and biophysical research communications.
[106] Evi Kostenis,et al. Fluid Shear Stress Differentially Regulates gpr3, gpr6, and gpr12 Expression in Human Umbilical Vein Endothelial Cells , 2003, Cellular Physiology and Biochemistry.
[107] Koichi Sato,et al. High-Density Lipoprotein Stimulates Endothelial Cell Migration and Survival Through Sphingosine 1-Phosphate and Its Receptors , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[108] J. P. Hobson,et al. Role of the Sphingosine-1-Phosphate Receptor EDG-1 in PDGF-Induced Cell Motility , 2001, Science.
[109] W. Santos,et al. Lysophosphatidic Acid-induced Mitogenesis Is Regulated by Lipid Phosphate Phosphatases and Is Edg-receptor Independent* , 2001, The Journal of Biological Chemistry.
[110] M. Kuzuya,et al. Induction of macrophage VEGF in response to oxidized LDL and VEGF accumulation in human atherosclerotic lesions. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[111] N. Nirmala,et al. Expression and characterization of a 5-oxo-6E,8Z,11Z,14Z-eicosatetraenoic acid receptor highly expressed on human eosinophils and neutrophils. , 2003, Molecular pharmacology.
[112] S. Agaugué,et al. Mature Dendritic Cell Generation Promoted by Lysophosphatidylcholine1 , 2002, The Journal of Immunology.
[113] Y. Nishizuka,et al. Role of lysophosphatidylcholine in T-lymphocyte activation: involvement of phospholipase A2 in signal transduction through protein kinase C. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[114] H. Schaller,et al. Sphingosine-1-phosphate is a high-affinity ligand for the G protein-coupled receptor GPR6 from mouse and induces intracellular Ca2+ release by activating the sphingosine-kinase pathway. , 2003, Biochemical and biophysical research communications.
[115] Richard D. Ye,et al. The Lysophospholipid Receptor G2A Activates a Specific Combination of G Proteins and Promotes Apoptosis* , 2003, The Journal of Biological Chemistry.
[116] J. V. Moran,et al. Initial sequencing and analysis of the human genome. , 2001, Nature.
[117] G. Assmann,et al. HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3. , 2004, The Journal of clinical investigation.
[118] R. Lefkowitz,et al. Heptahelical Receptor Signaling: Beyond the G Protein Paradigm , 1999, The Journal of cell biology.
[119] S. McColl,et al. Propionic acid‐induced calcium mobilization in human neutrophils , 1988, Journal of cellular physiology.
[120] Evi Kostenis,et al. Sphingosine 1-phosphate is a ligand of the human gpr3, gpr6 and gpr12 family of constitutively active G protein-coupled receptors. , 2002, Cellular signalling.
[121] S. Luoh,et al. Direct genetic demonstration of G alpha 13 coupling to the orphan G protein-coupled receptor G2A leading to RhoA-dependent actin rearrangement. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[122] K. Sugamura,et al. Prostaglandin D2 Selectively Induces Chemotaxis in T Helper Type 2 Cells, Eosinophils, and Basophils via Seven-Transmembrane Receptor Crth2 , 2001, The Journal of experimental medicine.
[123] K. Claffey,et al. Vascular Endothelial Cell Adherens Junction Assembly and Morphogenesis Induced by Sphingosine-1-Phosphate , 1999, Cell.
[124] S. Agaugué,et al. Sensing Environmental Lipids by Dendritic Cell Modulates Its Function 1 , 2004, The Journal of Immunology.
[125] H. Schaller,et al. Role of the G-Protein-Coupled Receptor GPR12 as High-Affinity Receptor for Sphingosylphosphorylcholine and Its Expression and Function in Brain Development , 2003, The Journal of Neuroscience.
[126] Y. Kawasawa,et al. Brain-specific expression of novel G-protein-coupled receptors, with homologies to Xenopus PSP24 and human GPR45. , 2000, Biochemical and biophysical research communications.
[127] K. Jakobs,et al. Sphingosylphosphorylcholine-biological functions and mechanisms of action. , 2002, Biochimica et biophysica acta.
[128] K. Hirata,et al. Expression of G2A, a Receptor for Lysophosphatidylcholine, by Macrophages in Murine, Rabbit, and Human Atherosclerotic Plaques , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[129] J. O'flaherty,et al. 5-hydroxyicosatetraenoate stimulates neutrophils by a stereospecific, G protein-linked mechanism. , 1993, The Journal of biological chemistry.
[130] B. O'dowd,et al. Identification of a Molecular Target of Psychosine and Its Role in Globoid Cell Formation , 2001, The Journal of cell biology.
[131] N. Voelkel,et al. Oxidative stress in severe pulmonary hypertension. , 2004, American journal of respiratory and critical care medicine.
[132] Y. Yatomi,et al. EDG3 is a functional receptor specific for sphingosine 1-phosphate and sphingosylphosphorylcholine with signaling characteristics distinct from EDG1 and AGR16. , 1999, Biochemical and biophysical research communications.
[133] G. Mills,et al. Lysophospholipid Growth Factors in the Initiation, Progression, Metastases, and Management of Ovarian Cancer , 2000, Annals of the New York Academy of Sciences.
[134] L. Moore,et al. The Pregnane X Receptor: A Promiscuous Xenobiotic Receptor That Has Diverged during Evolution , 2000 .
[135] H. D. de Vries,et al. Acute effects of oxidized low density lipoprotein on metabolic responses in macrophages. , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[136] A. Satterthwaite,et al. Mice lacking the orphan G protein-coupled receptor G2A develop a late-onset autoimmune syndrome. , 2001, Immunity.
[137] J. Lehmann,et al. Bile acids: natural ligands for an orphan nuclear receptor. , 1999, Science.
[138] D. Russell,et al. Bile acid biosynthesis. , 1992, Biochemistry.
[139] S. Spiegel,et al. Sphingosine 1-Phosphate-induced Cell Rounding and Neurite Retraction Are Mediated by the G Protein-coupled Receptor H218* , 1999, The Journal of Biological Chemistry.
[140] Duane D. Miller,et al. A novel membrane receptor with high affinity for lysosphingomyelin and sphingosine 1‐phosphate in atrial myocytes. , 1996, The EMBO journal.
[141] J. Rokach,et al. Interactions between 5-oxo-ETE and chemokines in stimulating eosinophils. , 2002, Advances in experimental medicine and biology.
[142] Michael D. Davis,et al. The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors* , 2002, The Journal of Biological Chemistry.
[143] P. Thomas,et al. Cloning, expression, and characterization of a membrane progestin receptor and evidence it is an intermediary in meiotic maturation of fish oocytes , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[144] L. Baudhuin,et al. Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1 , 2000, Nature Cell Biology.
[145] M. L. Beau,et al. A DNA damage and stress inducible G protein-coupled receptor blocks cells in G2/M. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[146] J. Maller. Fishing at the Cell Surface , 2003, Science.
[147] R. Proia,et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1 , 2004, Nature.
[148] D. Farningham,et al. The role of propionate and acetate in the control of food intake in sheep , 1993, British Journal of Nutrition.
[149] B. Olde,et al. A human cell surface receptor activated by free fatty acids and thiazolidinedione drugs. , 2003, Biochemical and biophysical research communications.
[150] M. Yamamoto,et al. Vitamin D‐binding protein (group‐specific component) is the sole serum protein required for macrophage activation after treatment of peritoneal cells with lysophosphatidylcholine , 1993, Immunology and cell biology.
[151] R. Hundal,et al. Lysophosphatidylcholine stimulates phospholipase D activity in mouse peritoneal macrophages. , 1999, Journal of lipid research.
[152] T. Sasaoka,et al. Pioglitazone Ameliorates Tumor Necrosis Factor-α–Induced Insulin Resistance by a Mechanism Independent of Adipogenic Activity of Peroxisome Proliferator–Activated Receptor-γ , 2001 .
[153] T. Sasaki,et al. Lysophosphatidylcholine plays an essential role in the mitogenic effect of oxidized low density lipoprotein on murine macrophages. , 1994, The Journal of biological chemistry.
[154] J. Halperin,et al. Anticancer effects of thiazolidinediones are independent of peroxisome proliferator-activated receptor gamma and mediated by inhibition of translation initiation. , 2001, Cancer research.
[155] Y. Yatomi,et al. EDG1 Is a Functional Sphingosine-1-phosphate Receptor That Is Linked via a Gi/o to Multiple Signaling Pathways, Including Phospholipase C Activation, Ca2+Mobilization, Ras-Mitogen-activated Protein Kinase Activation, and Adenylate Cyclase Inhibition* , 1998, The Journal of Biological Chemistry.
[156] H. Ochi,et al. Lysophosphatidylcholine increases expression of heparin-binding epidermal growth factor-like growth factor in human T lymphocytes. , 1997, Circulation research.
[157] Romain M. Wolf,et al. Proton-sensing G-protein-coupled receptors , 2003, Nature.
[158] C. Darimont,et al. A Human Cellular Model for Studying the Regulation of Glucagon-Like Peptide-1 Secretion. , 2001, Endocrinology.
[159] J. Chun,et al. The LPA receptors. , 2001, Prostaglandins & other lipid mediators.